Skip to main content

Vitamin D Autocrine System and Cancer

  • Chapter
Biologic Effects of Light 2001
  • 165 Accesses

Abstract

Epidemiological and biochemical evidence strongly implicates a role for the active form of vitamin D, 1α,25-dihydroxyvitamin D [1α,25(OH)2D], in the growth and differentiation of human breast, colon and prostate cells. Recently, our laboratory demonstrated the presence of mRNA and enzyme activity for 25-hydroxyvitamin D-1α-hydroxylase (1α-OHase), the enzyme responsible for the synthesis of 1α,25(OH)2D, in human cancer cells derived from those tissues. We further demonstrated a marked decrease in 1α-OHase activity in the primary cultures and cell lines of prostate cancer cells, compared to those found in the primary cultures of normal prostate cells. Transient or stable transfection of LNCaP prostate cancer cells with 1α-OHase cDNA greatly increased the 1α-OHase enzyme activity, and thereby their cellular response to the antiproliferative activity of 25(OH)D. These findings suggest that, by synthesizing la,25(OH)2D within the cell, the enzyme may play an autocrine role in modulating the proliferation and differentiation of breast, colon and prostate cells. Thus, higher circulating concentrations of 25(OH)D may be necessary for the extra-renal 1α-OHase to work at its maximum capacity to produce an adequate amount of 1α,25(OH)2D in tissues such as the breast, colon and prostate to regulate cell growth and protect them from becoming malignant. This may explain why people who live closer to the equator are less likely to die from cancers of the breast, colon and prostate.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Holick MF Vitamin D: photobiology, metabolism, and clinical applications. In: DeGroot L, Besser H, Burger HG, e al (eds) Endocrinology, 3rd Ed. W.B. Saundrs, Philadelphia, PA, U.S.A. pp.990–1013,1995.

    Google Scholar 

  2. Jones, G. Metabolism and catabolism of vitamin D, its metabolites, and clinically relevant analogs. In Vitamin D: Molecular biology, physiology, and clinical applications. Pages 57–84, Holick MF, ed. Humana Press, Totowa, New Jersey, 1999).

    Google Scholar 

  3. Mason, TJ, McKay FW, Hoover R, et al. Atlas of Cancer Mortality for U.S. Countries: 1950–69. U.S. Government Printing Office, Washington D.C. (DHEW Publication No. NIH 75–780, 1975.

    Google Scholar 

  4. Garland FC, Garland CF, Gorham MPH, Young BA. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19: 616–622, 1990.

    Article  Google Scholar 

  5. Hanchette CL and Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 70:2861–2869, 1992.

    Article  PubMed  CAS  Google Scholar 

  6. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Inter J Epidemiol 9:227–231, 1980.

    Article  CAS  Google Scholar 

  7. Kampman E. Giovannucci E. van’t Veer P. Rimm E. Stampfer MJ. Colditz GA. Kok FJ. Willett WC. Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies. Am J Epidemiol 1994; 139: 16–29.

    PubMed  CAS  Google Scholar 

  8. Kearney J, Giovannucci E, Rimm EB, et al. Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol 1996;143(9):907–17.

    Article  PubMed  CAS  Google Scholar 

  9. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study [see comments]. Lancet 1989;2(8673):1176–8.

    Article  PubMed  CAS  Google Scholar 

  10. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes and Control 11:847–852, 2000.

    Article  PubMed  CAS  Google Scholar 

  11. Colston K. Vitamin D and breast cancer: Therapeutic potential of new vitamin D analogs. In: Feldman D, Glorieux F, and Pike W (eds) Vitamin D. Academic Press, pp. 1107–1123, 1997.

    Google Scholar 

  12. Brasitus TA, Sitrin MD. Chemoprevention of colon cancer by vitamin D3 and its metabolites/analogs. In: Feldman D, Glorieux F, and Pike W (eds) Vitamin D. Academic Press, pp. 1141–1154, 1997.

    Google Scholar 

  13. Miller GJ. Vitamin D and prostate cancer: biologic interactions and clinical potentials. Cancer and Metastasis Reviews 17:353–360, 1999.

    Article  CAS  Google Scholar 

  14. Lointier P, Meggouh F, Dechelotte P, Pezet D, Ferrier C, Chipponi J, Saez S. 1,25-Dihydroxyvitamin D3 receptors and human colon adenocarcinoma. Br J Surg 78:435–439, 1991.

    Article  PubMed  CAS  Google Scholar 

  15. Meggouh F, Lointier P, Pezet D, Saez S. Evidence of 1,25-Dihydroxyvitamin D3 receptors in human digestive mucosa and carcinoma tissue biopsies taken at different levels of the digestive tract in 152 patients. J steroid Biochem 36:143–147, 1990.

    Article  PubMed  CAS  Google Scholar 

  16. Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Evans SR. Cancer Res 53:3712–18, 1993.

    PubMed  CAS  Google Scholar 

  17. Zhuang SH, Schwartz GG, Cameron D, Burnstein KL. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines. Mol Cellular Endocrinology 126:83–90, 1997.

    Article  CAS  Google Scholar 

  18. Colston KW, Berger U, Coombes RC. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1: 185–191, 1989.

    Google Scholar 

  19. Carroll KK, Jacobson EA, Eckel LA, Newmark HL. Calcium and carcinogenesis of the mammary gland. Am J Clin Nutr. 54, 206S–208S, 1991.

    PubMed  CAS  Google Scholar 

  20. Osborn JL, Schwartz GG, Smith DC, Bahnson R, Day R, Trump DL. Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer. Urol Oncol 1:195–198, 1995.

    Article  PubMed  CAS  Google Scholar 

  21. Gross C, Stamey T, Hancock S, Feldman D. Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol). J Urology 159:2035–2040, 1998.

    Article  CAS  Google Scholar 

  22. Schwartz GG. Ph.D. Dissertation, Dept. Epidemiology, Univ of North Carolina at Chapel Hill, 1993.

    Google Scholar 

  23. Corder EH, Guess HA, Hulka BS, Friedman GD, Sadler M, Vollmer RT, Lobaugh B, Drezner MK, Vogelman JH, Orentreich N. Vitamin D and prostate cancer: A prediagnostic study with stored sera. Cancer Epidemiol Biomarkers & Prev. 2, 467–472, 1993.

    CAS  Google Scholar 

  24. Nomura AMY, Stemmermann GN, Lee J, Kolonel LN, Chen TC, Turner A, Holick MF. Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States). Cancer Causes and Control 9:425–432, 1998.

    Article  PubMed  CAS  Google Scholar 

  25. Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomark Prev 5:121–126. 1996.

    CAS  Google Scholar 

  26. Miller WL, Portale AA. Vitamin D 1α-hydroxylase. TEM 11:315–319,2000

    PubMed  CAS  Google Scholar 

  27. Kong XF, Zhu XH, Pei YL, Jackson DM, Holick MF. Molecular cloning, characterization, and promoter analysis of the human 25-hydroxhvitamin D3-1α-hydroxylase gene. Proc Natl Acad Sci 96:6988–6993, 1999.

    Article  PubMed  CAS  Google Scholar 

  28. Cross HS, Peterlik M, Reddy GS, Schuster I. Vitamin D Metabolism in Human Colon Adenocarcinoma-derived Caco-2 Cells. J Steroid Biochem Mol Biol. (62)1:21–28, 1997.

    Article  Google Scholar 

  29. Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR, Lipkin MS, Holick MF. 25-hydroxyvitamin D3 in normal and malignant colon tissue. The Lancet. 2001;367(9269) 1673–4.

    Article  Google Scholar 

  30. Cross HS, Bareis P, Hofer H, Bischof MG, Bajna E, Kriwanek S, Bonner E, Peterlik M. Steroids 66:287–292, 2001.

    Article  PubMed  CAS  Google Scholar 

  31. Schwartz GG, Whitlatch LW, and Chen TC, Lokeshwar BL, Holick MF. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol, Biomark & Prev 7:391–395, 1998.

    CAS  Google Scholar 

  32. Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1α,25-dihydroxyvitamin D2 for prostate cancer therapy. Clin Cancer Res 6: 901–908, 2000.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Chen, T.C., Holick, M.F. (2002). Vitamin D Autocrine System and Cancer. In: Holick, M.F. (eds) Biologic Effects of Light 2001. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0937-0_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0937-0_23

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5313-3

  • Online ISBN: 978-1-4615-0937-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics